# Endoscopic Vessel Harvesting Systems Market

> Endoscopic Vessel Harvesting Systems Market Research Report: Size, Share, Trend Analysis By Product (EVH Systems, Endoscopes, and Accessories), By Usability (Reusable and Disposable), By Applications (Coronary Artery Disease (CAD), and Peripheral Artery Disease (PAD), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.0%
- **2024:** $ 0.53 Billion
- **2025:** $ 0.55 Billion
- **2035:** $ 0.82 Billion
- **Key Players:** Medtronic (US), Stryker (US), Boston Scientific (US), Terumo (JP), B. Braun Melsungen AG (DE), LivaNova (GB), Cardinal Health (US), Ethicon (US)

**Report ID:** MRFR/HC/20465-HCR · **Pages:** 128 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** May 15, 2026

**URL:** https://www.marketresearchfuture.com/reports/endoscopic-vessel-harvesting-systems-market-22065

---

## Market Summary

## **Global Endoscopic Vessel Harvesting Systems Market Overview**

The Endoscopic Vessel Harvesting Systems Market was valued at USD 0.51 billion in 2023. The Endoscopic Vessel Harvesting Systems Market industry is projected to grow from USD 0.53 billion in 2024 to USD 0.70 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.00% during the forecast period (2024 - 2032). 

The increasing rates of cardiovascular illnesses and rising preference for minimally invasive surgery are the primary market drivers propelling the market's expansion.

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

HEMOPRO technology with cutting and sealing to ensure optimal lumen quality during coronary artery bypass graft (CABG) surgery and less thermal effect was introduced in June 2023 when MAQUET Cardiovascular unveiled the VASOVIEW HEMOPRO 2 Endoscopic Vessel Harvesting (EVH) System. An example is the existence of another minimally invasive system which is known as VASOVIEW HEMOPRO 2.

In May 2021, PENTAX Medical, a subsidiary of HOYA Group, and Jiangsu Vedkang Medical Science and Technology Co., Ltd. announced the formation of PENTAX Medical Therapeutics (Jiangsu) Co., Ltd., aimed at developing single-use therapeutic products for flexible medical endoscopy market.

In January 2022, Getinge enrolled its EVH Circle of Excellence with some of the most committed clinicians conducting endoscopic vessel harvesting (EVH) procedures.

Getinge included some of the most dedicated clinicians performing EVH procedures in North America within their EVH Circle of Excellence.

LivaNova claimed that its Memo 4D semi-rigid mitral annuloplasty ring has been approved by the FDA to treat mitral regurgitation in 2021 while still compatible with LivaNova's Cineflex Ultraflexible endoscopic vessel harvesting system for more conservative cardiac surgeries.

FDA approved Saphena Medical’s Venapax endoscopic vessel harvesting system for use on patients undergoing coronary artery bypass grafting procedures who require saphenous vein harvests in 2020.

In 2020, Terumo Cardiovascular Systems Corporation released VirtuoSaph Plus for use as an endoscopic vascular harvesting device intended to enable surgeons to see clearly during operations as well as improve the efficacy and safety of the vessel harvesting process.

In 2020, MAQUET Holding B.V. & Co. KG (Getinge Group) revealed that its VASOVIEW 8 endoscopic vessel harvesting system had just got FDA approval; this new version is distinguished by ergonomic design and advanced imaging technology used in order to provide more precise vessel harvesting.

## **Endoscopic Vessel Harvesting Systems Market Trends**

Plaque accumulation is often the cause of coronary artery disease (CAD), which is a narrowing or blockage of the coronary arteries. The rising number of senior citizens and the prevalence of coronary artery disease (CAD) are driving the market CAGR. Additionally, as per an article distributed by PubMed Central in July 2022, coronary vein sickness, also called coronary illness, is much of the time brought about by diminished myocardial perfusion that causes infections like angina, myocardial dead tissue (MI), and cardiovascular breakdown, among others, and accounts for one-third to one-half of all cardiovascular illness. 

Thus, because of the great burden of coronary artery infection, the concentrated section is supposed to encounter development during the conjecture time of the study. Moreover, as per an article checked by Healthdirect Australia in June 2022, coronary illness is the most well-known reason for death in Australia, and a few risk factors for this incorporate smoking, excessive alcohol utilization, absence of activity, social disengagement, and being overweight or obese. 

Subsequently, the high weight of CAD in different nations is supposed to help the adoption of endoscopic vessel gathering methodology for its treatment.

Additionally, the expanded risk of CAD with the increasing age and the rising geriatric populace overall are other main considerations driving the segment's development. For example, as per an article updated by NCBI in November 2022, the frequency of CAD rises with age, regardless of gender. Also, the rising investment in CAD research is predicted to raise progressed endoscopic vessel harvesting methodology on the market.

The high-level clinical imaging innovation in the EVH gadgets empowered the specialists with further developed visualization abilities. For example, the integration of near-infrared fluorescence imaging in EVH gadgets considers constant visualization of blood vessels during the harvesting system, improving accuracy and diminishing the risk of harm to the vessels. The progression of EVH gadgets guarantees improved results in coronary artery bypass grafting (CABG) methods, which support market growth. Thus driving the Endoscopic Vessel Harvesting Systems market revenue.

## **Endoscopic Vessel Harvesting Systems Market Segment Insights**

### **Endoscopic Vessel Harvesting Systems Product Insights**

Based on Product, the Endoscopic Vessel Harvesting Systems Market segmentation includes EVH systems, endoscopes, and accessories. In 2023, the EVH systems segment dominated the market. The clinical necessity for minimally invasive methods in cardiac surgery, especially for operations like coronary artery bypass grafting (CABG), is what drives the demand for EVH devices. A crucial part of CABG surgery is endoscopic vascular harvesting, and EVH devices provide more benefits than open harvesting techniques. It is projected that this clinical necessity will increase demand for EVH systems in the context of cardiac surgery.

The endoscope category is anticipated to be the fastest growing. Endoscopes, which give top-quality vision of blood, allow specialists to precisely identify and assess the quality of blood vessels for harvesting. This visualization is important for vascular grafting treatment to find lasting success.

**Figure 1: Endoscopic Vessel Harvesting Systems Market, by Product, 2023 & 2032 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

### **Endoscopic Vessel Harvesting Systems Usability Insights**

Based on Usability, the Endoscopic Vessel Harvesting Systems Market segmentation includes reusable and disposable. In 2023, the reusable category generated the most income. Reusable EVH systems are usually less expensive since they can be cleaned and used repeatedly. Reusable systems may be more affordable in the long run for healthcare institutions with high procedure volumes, which would increase demand for this market. Additionally, healthcare institutions can select appropriate instruments and accessories with reusable EVH systems because of their increased flexibility and customization choices.

Because of its adaptability, the vessel harvesting process may be optimized and made more efficient, which increases demand for reusable systems.

The Endoscopic Vessel Harvesting Systems’ disposable segment market is anticipated to grow fastest during the forecast period. During surgical operations, endoscopes are covered and shielded by endoscope sheaths. In order to lower the danger of infection and avoid cross-contamination between patients, disposable sheaths are made to be used just once.

### **Endoscopic Vessel Harvesting Systems Application Insights**

Based on Application, the Endoscopic Vessel Harvesting Systems Market segmentation includes coronary artery disease (CAD) and [peripheral artery disease](../../../reports/peripheral-artery-disease-market-1540) (PAD). The coronary artery disease (CAD) category leads the market. Better CAD detection, diagnosis, and treatment are the result of more healthcare spending and easier access to healthcare. Modern diagnostic methods and medical technology allow for early identification of CAD, which facilitates prompt therapies to stop the disease's progression and lessen its consequences.

Furthermore, CAD is one of the world's top causes of mortality and has been increasing as a result of several lifestyle-related issues. Due to the increased risk of developing CAD with age, the aging population, in particular, raises the prevalence of the illness. It fuels the growing need for endoscopic vessel harvesting devices for CAD applications.

The Endoscopic Vessel Harvesting Systems market’s peripheral artery disease (PAD) segment is anticipated to grow fastest during the projection period. EVH devices allow vein harvesting for vascular bypass surgeries in patients with PAD in a less invasive manner. Endoscopic vessel harvesting is a beneficial choice for individuals with PAD who may have compromised health owing to underlying cardiovascular diseases since it minimizes surgical stress, postoperative discomfort, and recovery time when compared to standard open harvesting approaches.

### **Endoscopic Vessel Harvesting Systems Regional Insights**

By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Endoscopic Vessel Harvesting Systems market will dominate this market. North America has a huge burden of cardiovascular disorders (CVDs), including coronary artery sickness (CAD) and peripheral artery illness. Thus, there is a significant interest in successful treatment choices, including CABG medical procedures where endoscopic vessel harvesting frameworks are used. 

Furthermore, the need for these systems in the area is fueled by ongoing developments in endoscopic vessel harvesting systems, such as the creation of less invasive methods and robotically assisted operations.

Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

**Figure 2: ****Endoscopic Vessel Harvesting Systems Market Share By Region 2023 (USD Billion)**

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

Europe's Endoscopic Vessel Harvesting Systems market accounts for the second-largest market share. Europe boasts advanced medical services infrastructure, including modern clinics and surgical facilities equipped with the most recent medical innovations. This system works with the adoption of cutting-edge surgical strategies like endoscopic vessel harvesting. Further, the German Endoscopic Vessel Harvesting Systems market held the largest market share, and the UK Endoscopic Vessel Harvesting Systems market was the fastest-growing market in the European region.

The Asia-Pacific Endoscopic Vessel Harvesting Systems Market is expected to grow at the fastest CAGR from 2024 to 2032. Countries in the Asia Pacific area are expanding their medical services Investment to develop further medical services framework, access to clinical benefits, and patient results. This investment creates an atmosphere that is conducive to the use of cutting-edge medical technology like endoscopic vessel harvesting systems. Moreover, China’s Endoscopic Vessel Harvesting Systems market held the largest market share, and the Indian Endoscopic Vessel Harvesting Systems market was the fastest-growing market in the Asia-Pacific region.

## **Endoscopic Vessel Harvesting Systems Key Market Players & Competitive Insights**

The industry's leading players will keep investing heavily in R&D to expand their product lines, which will propel the Endoscopic Vessel Harvesting Systems market's growth. Contractual agreements, mergers and acquisitions, increased investments, collaboration with other companies, and the production of new products are examples of significant market developments. To increase their worldwide reach, market players also take part in a variety of strategic initiatives. In order to survive and expand in a more competitive and dynamic market, the Endoscopic Vessel Harvesting Systems industry must offer reasonably priced products and services.

One of the main strategies manufacturers use in the worldwide Endoscopic Vessel Harvesting Systems market is local manufacturing, which expands the market sector and helps customers by lowering running expenses. In recent years, some of the largest medicinal advantages have come from the Endoscopic Vessel Harvesting Systems sector. Major players in the Endoscopic Vessel Harvesting Systems market, including Getinge AB, Cardio Precision Ltd., Terumo Corporation, KARL STORZ SE & Co. KG, Livanova PLC, Medical Instruments Spa, and Saphena Medical, and others, are making investments in R&D activities in an effort to boost market demand.

Terumo Corp (Terumo) makes and markets clinical consideration items, including emergency clinic items, clinical items, and hardware. The organization's significant item classes incorporate drugs, blood packs, dispensable clinical gadgets, nourishing food supplements, cardiovascular frameworks, vascular grafts, [blood glucose monitoring](../../../reports/blood-glucose-monitoring-market-557) systems, medical electronics, peritoneal dialysis, and advanced thermometers. Its systems find applications in treatments performed inside blood vessels and vascular medical procedures. Terumo likewise works in blood centers to collect blood and handle it to address the necessity of transfusion in patients. In September 2022, Terumo Cardiovascular established its newest production facility in Cartago, Costa Rica's La Lima.

A MedTech business called CardioPrecision creates devices and technologies for the minimally invasive treatment of structural heart disease. The company's main focus was on the novel transcervical technique for minimally invasive aortic valve procedures and surgery. It enables medical professionals to carry out minimally invasive treatments using a tiny neck incision. 

Both transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) have been effectively performed using the company's CoreVista® devices. Similar advantages for patients and healthcare professionals are anticipated for other cardiovascular applications, such as TMVR, TEVAR, EVAR, and LVAD implantation. Less discomfort and a quicker recovery are two main advantages. 

Reduced chance of infection and transfusion, as well as less blood loss and a much shorter hospital stay, are possible secondary advantages. CardioPrecision presented their CoreVista gadget suite in September 2021 for use in endoscopic vessel harvesting (EVH) during coronary artery bypass grafting (CABG) activities.

### **Key Companies in the Endoscopic Vessel Harvesting Systems market include**

### **Endoscopic Vessel Harvesting Systems Industry Developments**

**January 2022:** Getinge named the Getinge EVH Circle of Excellence in honor of some of the most committed medical professionals in North America who undertake endoscopic vascular harvesting (EVH) treatments.

**January 2021:** Venapax is a unitary endoscopic vessel harvesting device manufactured by Saphena Medical. Premier's highly dedicated SURPASS (Synergizing for Unparalleled Results in Procurement and Strategic Sourcing) initiative awarded Saphena Medical a contract in the EVH category. One of the biggest performance enhancement firms in the United States is Premier Inc.

## **Endoscopic Vessel Harvesting Systems Market Segmentation**

### **Endoscopic Vessel Harvesting Systems Product Outlook**

### **Endoscopic Vessel Harvesting Systems Usability Outlook**

### **Endoscopic Vessel Harvesting Systems Application Outlook**

### **Endoscopic Vessel Harvesting Systems Regional Outlook**

## Market Drivers

### Increasing Geriatric Population

The Endoscopic Vessel Harvesting Systems Market is poised for growth due to the increasing geriatric population, which is more susceptible to cardiovascular diseases and other health issues requiring surgical intervention. As the global population ages, the demand for effective surgical solutions, including endoscopic vessel harvesting, is likely to escalate. Older patients often face higher risks during traditional surgeries, making minimally invasive options more appealing. Market projections indicate that the geriatric demographic will significantly influence the demand for endoscopic systems, as healthcare providers seek to offer safer alternatives for this vulnerable population. This demographic shift may lead to a sustained increase in the adoption of endoscopic vessel harvesting systems in surgical practices.

### Focus on Patient Safety and Outcomes

In the Endoscopic Vessel Harvesting Systems Market, there is an increasing emphasis on patient safety and improved surgical outcomes. Healthcare providers are prioritizing technologies that minimize risks associated with traditional harvesting methods. The adoption of endoscopic systems is seen as a proactive measure to enhance patient safety, as these systems are designed to reduce trauma and complications. Data indicates that hospitals implementing these systems report lower rates of infection and better overall patient satisfaction. As patient safety becomes a central focus in surgical practices, the demand for endoscopic vessel harvesting systems is likely to grow. This trend reflects a broader commitment within the healthcare sector to prioritize patient-centered care and improve surgical results.

### Rising Incidence of Cardiovascular Diseases

The Endoscopic Vessel Harvesting Systems Market is significantly influenced by the rising incidence of cardiovascular diseases worldwide. As the prevalence of conditions such as coronary artery disease continues to increase, the demand for surgical interventions, including bypass surgeries, is expected to rise. Endoscopic vessel harvesting systems play a crucial role in these procedures by providing a less invasive option for obtaining grafts. Market analysis indicates that cardiovascular surgeries are projected to grow, thereby driving the need for efficient harvesting systems. This trend suggests that healthcare providers will increasingly rely on endoscopic techniques to meet the growing surgical demands associated with cardiovascular health, potentially leading to a robust expansion of the market.

### Shift Towards Minimally Invasive Procedures

The Endoscopic Vessel Harvesting Systems Market is witnessing a notable shift towards minimally invasive surgical techniques. This trend is largely driven by the increasing preference for procedures that result in reduced patient recovery times and lower postoperative pain. Minimally invasive approaches, such as endoscopic vessel harvesting, are associated with fewer complications compared to traditional open surgeries. As healthcare providers aim to enhance patient outcomes, the demand for these systems is expected to rise. Market data suggests that minimally invasive procedures account for a significant portion of surgical interventions, indicating a robust growth trajectory for endoscopic vessel harvesting systems. This shift not only benefits patients but also healthcare facilities, as it can lead to shorter hospital stays and reduced healthcare costs.

### Technological Advancements in Endoscopic Vessel Harvesting Systems

The Endoscopic Vessel Harvesting Systems Market is experiencing a surge in technological advancements that enhance the efficiency and effectiveness of procedures. Innovations such as improved imaging techniques and robotic-assisted systems are becoming increasingly prevalent. These advancements not only facilitate better visualization during surgeries but also reduce the risk of complications. The integration of artificial intelligence in surgical planning and execution is also gaining traction, potentially leading to more precise outcomes. As a result, the market is projected to grow at a compound annual growth rate of approximately 8% over the next few years, driven by these technological improvements. Surgeons are likely to adopt these advanced systems, which may lead to a higher demand for endoscopic vessel harvesting solutions.

## Future Outlook

The Endoscopic Vessel Harvesting Systems Market is projected to grow at a 4.0% CAGR from 2025 to 2035, driven by technological advancements, increasing demand for minimally invasive procedures, and rising cardiovascular diseases.

**New opportunities:**

- Development of integrated robotic-assisted harvesting systems
- Expansion into emerging markets with tailored solutions
- Partnerships with hospitals for training and support services

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Product: EVH Systems (Largest) vs. Accessories (Fastest-Growing)

In the Endoscopic Vessel Harvesting Systems Market, the main segment values include EVH systems, endoscopes, and accessories. EVH systems hold the largest share due to their central role in minimally invasive surgeries, facilitating a significant portion of the market. Following this, accessories, which include various tools and attachments used in conjunction with EVH systems, are starting to carve out a larger market share, demonstrating a growing importance as surgical techniques advance and evolve toward enhanced efficiency and effectiveness.

Endoscopic Vessel Harvesting Systems Market (Dominant) vs. Accessories (Emerging)

The Endoscopic Vessel Harvesting Systems Market represent the dominant segment in the market due to their pivotal function in facilitating minimally invasive cardiac procedures. These systems provide surgeons with vital tools that improve patient outcomes through less invasive approaches, which in turn drives their widespread adoption in hospitals and surgical centers. On the other hand, accessories are emerging as a rapidly growing segment, incorporating advanced designs and enhancing the overall effectiveness of EVH systems. As technology continues to innovate, the need for specialized accessories tailored to specific surgical requirements is escalating, allowing them to play an increasingly integral role in the success of endoscopic vessel harvesting.

### By Usability: Reusable (Largest) vs. Disposable (Fastest-Growing)

In the Endoscopic Vessel Harvesting Systems Market, the usability segment showcases a notable distribution between the reusable and disposable systems. The reusable systems command a significant portion of the market due to their cost-effectiveness and reliability in clinical settings. They have established a strong foothold among healthcare providers who value sustainability and long-term investments in medical technology. Conversely, disposable endoscopic systems are gaining traction, appealing to facilities seeking convenience and reduced risk of cross-contamination during surgeries.

Usability: Reusable (Dominant) vs. Disposable (Emerging)

The reusable endoscopic vessel harvesting systems hold a dominant position in the market, offering considerable advantages in terms of cost per use and reliability. These systems are often preferred in environments where budgets allow for their purchase and maintenance, making them a staple in surgical practices. On the other hand, disposable systems are emerging rapidly, primarily driven by their ease of use and the growing emphasis on [infection control](https://www.marketresearchfuture.com/reports/infection-control-market-5901). Facilities adopting disposable options benefit from reduced cleaning time and the assurance of using new, sterile devices for each procedure. Both segment values address specific needs within surgical contexts, enhancing operational efficiency and patient safety.

### By Application: Coronary Artery Disease (Largest) vs. Peripheral Artery Disease (Fastest-Growing)

In the Endoscopic Vessel Harvesting Systems Market, the application segment is primarily dominated by the management of Coronary Artery Disease (CAD). This segment holds the largest share, driven by the high prevalence of CAD and the increasing number of surgical interventions that utilize endoscopic harvesting techniques. [Peripheral Artery Disease](https://www.marketresearchfuture.com/reports/peripheral-artery-disease-market-1540) (PAD), while smaller in comparison, is rapidly gaining traction, largely due to the rising awareness and advancements in minimally invasive surgical options that enhance patient recovery.

Application: CAD (Dominant) vs. PAD (Emerging)

Coronary Artery Disease (CAD) serves as the dominant application in the Endoscopic Vessel Harvesting Systems Market, owing to its established treatment methodologies and the critical need for effective grafts in coronary bypass surgeries. The segment benefits from an extensive patient base, supported by ongoing innovations in surgical techniques that improve outcomes. In contrast, Peripheral Artery Disease (PAD) is emerging as a significant area of growth, driven by increasing incidences owing to lifestyle changes and an aging population. Enhanced awareness of PAD and its treatment options, combined with technological advancements in endoscopic tools, positions this segment for rapid development, appealing to surgical settings aiming to adopt cutting-edge techniques for optimal patient care.

## Regional Market Share Analysis

### North America : Healthcare Innovation Leader

North America is the largest market for Endoscopic Vessel Harvesting Systems Market, holding approximately 45% of the global market share. The region benefits from advanced healthcare infrastructure, high adoption rates of minimally invasive surgeries, and strong regulatory support. The demand is further driven by an aging population and increasing prevalence of cardiovascular diseases, prompting healthcare providers to adopt innovative surgical techniques. The United States is the leading country in this market, with major players like Medtronic, Stryker, and Boston Scientific headquartered there. The competitive landscape is characterized by continuous innovation and strategic partnerships among key players. Canada also contributes significantly to the market, focusing on enhancing surgical outcomes through advanced technologies and training programs.

### Europe : Emerging Market Dynamics

Europe is the second-largest market for Endoscopic Vessel Harvesting Systems Market, accounting for approximately 30% of the global market share. The region is witnessing growth due to increasing investments in healthcare technology, a rise in the number of surgical procedures, and supportive regulatory frameworks. Countries like Germany and the UK are leading the charge, with a focus on improving patient outcomes and reducing recovery times through minimally invasive techniques. Germany stands out as a key player in the market, with a robust presence of companies like B. Braun Melsungen AG and Terumo. The competitive landscape is marked by collaborations between healthcare providers and technology firms to enhance surgical efficiency. The European market is also influenced by stringent regulations aimed at ensuring patient safety and efficacy of medical devices, fostering a culture of innovation.

### Asia-Pacific : Rapidly Growing Healthcare Sector

Asia-Pacific is rapidly emerging as a significant market for Endoscopic Vessel Harvesting Systems Market, holding about 20% of the global market share. The growth is driven by increasing healthcare expenditure, a rising population, and a growing prevalence of lifestyle-related diseases. Countries like Japan and China are at the forefront, with expanding healthcare infrastructure and a shift towards advanced surgical techniques to improve patient care. Japan is a key player in this market, with companies like Terumo leading the way in innovation. The competitive landscape is evolving, with local manufacturers entering the market to meet the growing demand. Additionally, government initiatives aimed at enhancing healthcare access and quality are further propelling market growth, making Asia-Pacific a focal point for future investments in surgical technologies.

### Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually emerging in the Endoscopic Vessel Harvesting Systems Market, currently holding about 5% of the global market share. The growth is primarily driven by increasing healthcare investments, a rising number of surgical procedures, and a growing awareness of minimally invasive techniques. Countries like South Africa and the UAE are leading the way, focusing on enhancing healthcare infrastructure and attracting foreign investments to improve surgical capabilities. South Africa is a notable player in this market, with a growing number of healthcare facilities adopting advanced surgical technologies. The competitive landscape is characterized by collaborations between local and international firms to enhance service delivery. Additionally, government initiatives aimed at improving healthcare access and quality are expected to further stimulate market growth in the region, making it an attractive area for future investments.

## Competitive Benchmarking

The Endoscopic Vessel Harvesting Systems Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for minimally invasive surgical procedures. Key players such as Medtronic (US), Stryker (US), and Boston Scientific (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Medtronic (US) focuses on innovation through the development of advanced robotic-assisted systems, while Stryker (US) emphasizes strategic partnerships to expand its product offerings. Boston Scientific (US) appears to be leveraging its strong research and development capabilities to introduce novel solutions, thereby shaping a competitive environment that prioritizes technological superiority and operational efficiency.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain resilience. The market structure is moderately fragmented, with several players vying for market share. This fragmentation allows for a diverse range of products and innovations, although it also intensifies competition among key players. The collective influence of these companies is significant, as they continuously adapt to market demands and regulatory changes, thereby shaping the overall landscape of the Endoscopic Vessel Harvesting Systems Market.

In August  Medtronic (US) announced the launch of its latest endoscopic vessel harvesting system, which integrates advanced imaging technology to enhance surgical precision. This strategic move is likely to solidify Medtronic's position as a leader in the market, as it addresses the growing demand for improved surgical outcomes and patient safety. The introduction of this system not only showcases Medtronic's commitment to innovation but also reflects a broader trend towards the integration of cutting-edge technology in surgical procedures.Similarly, in July 2025, Stryker (US) entered into a partnership with a leading healthcare technology firm to develop AI-driven analytics tools for its endoscopic systems. This collaboration is expected to enhance the functionality of Stryker's products, providing surgeons with real-time data to inform their decisions during procedures. The strategic importance of this partnership lies in its potential to improve surgical efficiency and patient outcomes, thereby reinforcing Stryker's competitive edge in the market.

In September  Boston Scientific (US) expanded its product line by acquiring a smaller firm specializing in innovative vessel harvesting technologies. This acquisition is indicative of Boston Scientific's strategy to bolster its portfolio and enhance its market share. By integrating these new technologies, the company aims to offer a more comprehensive suite of solutions to healthcare providers, which could lead to increased adoption of its products in surgical settings.

As of October  the Endoscopic Vessel Harvesting Systems Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence. These trends are reshaping the competitive landscape, as companies seek to differentiate themselves through innovative solutions rather than price competition. Strategic alliances are becoming increasingly important, enabling firms to pool resources and expertise to address complex market challenges. Looking ahead, it is likely that competitive differentiation will evolve, with a stronger emphasis on technological advancements, supply chain reliability, and the ability to deliver superior patient outcomes.

## Recent News & Developments

**January 2022:** Getinge named the Getinge EVH Circle of Excellence in honor of some of the most committed medical professionals in North America who undertake endoscopic vascular harvesting (EVH) treatments.

**January 2021:** Venapax is a unitary endoscopic vessel harvesting device manufactured by Saphena Medical. Premier's highly dedicated SURPASS (Synergizing for Unparalleled Results in Procurement and Strategic Sourcing) initiative awarded Saphena Medical a contract in the EVH category. One of the biggest performance enhancement firms in the United States is Premier Inc.

## Report Scope

| MARKET SIZE 2024 | 0.53(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 0.5512(USD Billion) |
| MARKET SIZE 2035 | 0.8161(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.0% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Medtronic (US), Stryker (US), Boston Scientific (US), Terumo (JP), B. Braun Melsungen AG (DE), LivaNova (GB), Cardinal Health (US), Ethicon (US) |
| Segments Covered | Product, Usability, Applications, Region |
| Key Market Opportunities | Advancements in minimally invasive techniques enhance demand for Endoscopic Vessel Harvesting Systems in surgical procedures. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation in Endoscopic Vessel Harvesting Systems, enhancing surgical outcomes. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation for the Endoscopic Vessel Harvesting Systems Market in 2035?**
A: The projected market valuation for the Endoscopic Vessel Harvesting Systems Market in 2035 is 0.8161 USD Billion.

**Q: What was the overall market valuation for the Endoscopic Vessel Harvesting Systems Market in 2024?**
A: The overall market valuation for the Endoscopic Vessel Harvesting Systems Market in 2024 was 0.53 USD Billion.

**Q: What is the expected CAGR for the Endoscopic Vessel Harvesting Systems Market from 2025 to 2035?**
A: The expected CAGR for the Endoscopic Vessel Harvesting Systems Market during the forecast period 2025 - 2035 is 4.0%.

**Q: Which companies are considered key players in the Endoscopic Vessel Harvesting Systems Market?**
A: Key players in the Endoscopic Vessel Harvesting Systems Market include Medtronic, Stryker, Boston Scientific, Terumo, B. Braun Melsungen AG, LivaNova, Cardinal Health, and Ethicon.

**Q: What are the projected valuations for the different product segments in the Endoscopic Vessel Harvesting Systems Market?**
A: The projected valuations for product segments are 0.4 USD Billion for EVH systems, 0.25 USD Billion for endoscopes, and 0.16 USD Billion for accessories.

**Q: How do the reusable and disposable usability segments compare in terms of market valuation?**
A: The reusable segment is projected to reach 0.48 USD Billion, while the disposable segment is expected to reach 0.3361 USD Billion.

**Q: What applications are driving growth in the Endoscopic Vessel Harvesting Systems Market?**
A: The applications driving growth include Coronary Artery Disease (CAD) with a projected valuation of 0.48 USD Billion and Peripheral Artery Disease (PAD) at 0.3361 USD Billion.

**Q: What trends are influencing the Endoscopic Vessel Harvesting Systems Market in 2025?**
A: Trends influencing the market in 2025 include advancements in technology and increasing demand for minimally invasive surgical procedures.

**Q: How does the Endoscopic Vessel Harvesting Systems Market's growth compare to other medical device markets?**
A: The Endoscopic Vessel Harvesting Systems Market's growth, with a CAGR of 4.0%, suggests a steady expansion compared to other medical device markets.

**Q: What factors could impact the future growth of the Endoscopic Vessel Harvesting Systems Market?**
A: Factors that could impact future growth include regulatory changes, technological advancements, and shifts in healthcare provider preferences.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/endoscopic-vessel-harvesting-systems-market-22065*
